1 Trinchieri G. Biology of natural killer cells, Adv Immunol, 1989, 47, 187–376.[Medline]
2 Perussia B, Starr S, Abraham S, Fanning V & Trinchieri G. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1, J Immunol, 1983, 130, 2133–2141.[Abstract]
3 Scharton TM & Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania majorin mice, J Exp Med, 1993, 178, 567–577.[Abstract/Free Full Text]
4 Scharton-Kersten T & Scott P. The role of the innate immune response in Th1 cell development following Leishmania majorinfection, J Leukocyte Biol, 1995, 57, 515–522.[Abstract]
5 Perussia B, Fanning V & Trinchieri G. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8, J Immunol, 1983, 131, 223–231.[Abstract]
6 Lotzova E, Savary CA & Champlin RE. Genesis of human oncolytic natural killer cells from primitive CD34+ CD33–bone marrow progenitors, J Immunol, 1993, 151, 5263–5269.
7 Miller JS, Alley KA & McGlave P. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+NK progenitor, Blood, 1994, 83, 2594–2601.[Abstract/Free Full Text]
8 Miller JS, Verfaillie C & McGlave P. The generation of human natural killer cells from CD34+/DR-primitive progenitors in long-term bone marrow culture, Blood, 1992, 80, 2182–2187.[Abstract/Free Full Text]
9 Shibuya A, Nagayoshi K, Nakamura K & Nakauchi H. Lymphokine requirement for the generation of natural killer cells from CD34+hematopoietic progenitor cells, Blood, 1995, 85, 3538–3546.[Abstract/Free Full Text]
10 Silva MR, Hoffman R, Srour EF & Ascensao JL. Generation of human natural killer cells from immature progenitors does not require marrow stromal cells, Blood, 1994, 84, 841–846.[Abstract/Free Full Text]
11 Mrozek E, Anderson P & Caligiuri MA. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+hematopoietic progenitor cells, Blood, 1996, 87, 2632–2640.[Abstract/Free Full Text]
12 Cicuttini FM, Martin M, Petrie HT & Boyd AW. A novel population of natural killer progenitor cells isolated from human umbilical cord blood, J Immunol, 1993, 150, 29–37.
13 Hackett J, Jr, Bennett M & Kumar V. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor, J Immunol, 1985, 134, 3731–3738.[Abstract]
14 Moore T, Bennett M & Kumar V. Transplantable NK cell progenitors in murine bone marrow, J Immunol, 1995, 154, 1653–1663.[Abstract]
15 Hackett J, Jr, Tutt M, Lipscomb M, Bennett M, Koo G & Kumar V. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+cells, J Immunol, 1986, 136, 3124–3131.[Abstract]
16 Perussia B, Ramoni C, Anegon I, Cuturi M C, Faust J & Trinchieri G. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines, Nat Immun Cell Growth Regul, 1987, 6, 171–188.[Medline]
17 Hoffman RA, Kung PC, Hansen WP & Goldstein G. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood, Proc Natl Acad Sci USA, 1980, 77, 4914–4917.[Abstract/Free Full Text]
18 Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA & Fearon DT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2, Proc Natl Acad Sci USA, 1984, 81, 4510–4514.[Abstract/Free Full Text]
19 Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF & Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells, J Immunol, 1984, 133, 157–165.[Abstract]
20 Aramburu J, Balboa MA, Ramirez A, Silva A, Acevedo A, Sanchez-Madrid F, De Landazuri MO & Lopez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/ delta+T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody, J Immunol, 1990, 145, 3238–3247.
21 Lanier LL, Chang C & Phillips JH. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes, J Immunol, 1994, 153, 2417–2428.[Abstract]
22 Perussia B, Trinchieri G & Cerrottini JC. Functional studies of Fc receptor-bearing human lymphocytes: effect of treatment with proteolytic enzymes, J Immunol, 1979, 123, 681–687.[Abstract/Free Full Text]
23 Wysocki LJ & Sato VL. Panning for lymphocytes: a method for cell selection, Proc Natl Acad Sci USA, 1978, 75, 2844–2848.[Abstract/Free Full Text]
24 Toksoz D, Zsebo K, Smith K, Hu S, Brankow D, Suggs SV, Martin F & Williams DA. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membranebound and secreted forms of the human homolog of the steel gene factor, stem cell factor, Proc Natl Acad Sci USA, 1992, 89, 7350–7354.[Abstract/Free Full Text]
25 Ravetch JV & Perussia B. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type–specific expression of two genes that differ in single nucleotide substitutions, J Exp Med, 1989, 170, 481–497.[Abstract/Free Full Text]
26 Uphoff CC, Hu ZB, Gignac SM, Ma W, Rainey FA, Kreutz M, Ludwig WD & Drexler HG. Characterization of the monocyte-specific esterase (MSE) gene, Leukemia, 1994, 8, 1510–1526.[Medline]
27 Tabor, S. 1996. Phosphatases and Kinases. In Current Protocols in Molecular Biology. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, editors. John Wiley and Sons, Inc., New York. 3.10.1–3.10.5.
28 Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B & Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes, J Exp Med, 1987, 165, 1581–1594.[Abstract/Free Full Text]
29 Murphy M, Loudon R, Kobayashi M & Trinchieri G. Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation, J Exp Med, 1986, 164, 263–279.[Abstract/Free Full Text]
30 Anderson P, Nagler-Anderson C, O'Brien C, Levine H, Watkins S, Slayter H S, Blue M L & Schlossman S F. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+T lymphocytes, J Immunol, 1990, 144, 574–582.[Abstract]
31 Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X & Trinchieri G. Interleukin-12 production by human polymorphonuclear leukocytes, Eur J Immunol, 1995, 25, 1–5.[Medline]
32 Koizumi H, Liu CC, Zheng LM, Joag SV, Bayne NK, Holoshitz J & Young JD. Expression of perforin and serine esterases by human gamma/delta T cells, J Exp Med, 1991, 173, 499–502.[Abstract/Free Full Text]
33 Wagner L, Base W, Weisholzer M, Sexl V, Bognar H & Worman C. Detection of BLT-substrate-specific proteases in individual human peripheral blood leukocytes and bone marrow cells, J Immunol Methods, 1991, 142, 147–155.[Medline]
34 Nagler A, Lanier LL, Cwirla S & Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells, J Immunol, 1989, 143, 3183–3191.[Abstract]
35 Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Sheera J, London L & Perussia B. Response of resting human peripheral blood natural killer cells to interleukin 2, J Exp Med, 1984, 160, 1147–1169.[Abstract/Free Full Text]
36 Matos ME, Schnier GS, Beecher MS, Ashman LK, William DE & Caligiuri MA. Expression of a functional c-kit receptor on a subset of natural killer cells, J Exp Med, 1993, 178, 1079–1084.[Abstract/Free Full Text]
37 Fleit HB, Wright SD, Durie CJ, Valinsky JE & Unkeless JC. Ontogeny of Fc receptors and complement receptor (CR3) during human myeloid differentiation, J Clin Invest, 1984, 73, 516–525.[Medline]
38 Phillips JH, Chang CW & Lanier LL. Plateletinduced expression of Fc gamma RIII (CD16) on human monocytes, Eur J Immunol, 1991, 21, 895–899.[Medline]
39 Miller JS, Delkers S, Verfaillie C & McGlave P. Role of monocytes in the expansion of human activated natural killer cells, Blood, 1992, 80, 2221–2229.[Abstract/Free Full Text]
40 Giorda R, Rudert WU, Vavassori C, Chambers WH, Hiserodt JC & Trucco M. NKR-P1, a signal transduction molecule on natural killer cells, Science (Wash DC), 1990, 249, 1298–1300.[Abstract/Free Full Text]
41 Bezouska K, Yuen CT, O'Brien J, Childs RA, Chai W, Lawson AM, Drbal K, Fiserova A, Pospisil M & Feizi T. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity, Nature (Lond), 1994, 372, 150–157.[Medline]
42 Bezouska K, Vlahas G, Horvath O, Jinochova G, Fiserova A, Giorda R, Chambers WH, Feizi T & Pospisil M. Rat natural killer cell antigen, NKR-P1, related to C-type animal lectins is a carbohydrate-binding protein, J Biol Chem, 1994, 269, 16945–16952.[Abstract/Free Full Text]
43 Robertson MJ, Caligiuri MA, Manley TJ, Levine H & Ritz J. Human natural killer cell adhesion molecules: differential expression after activation and participation in cytolysis, J Immunol, 1990, 145, 3194–3201.[Abstract]
44 Schmits R, Kundig TM, Baker DM, Shumaker G, Simard JJL, Duncan G, Wakeham A, Shahinian A, van der Heiden A, Bachmann MF, Ohashi PS et al.. LFA- 1–deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor, J Exp Med, 1996, 183, 1415–1426.[Abstract/Free Full Text]
45 Ryan JC, Turck J, Niemi EC, Yokoyama WM & Seaman WE. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules, J Immunol, 1992, 149, 1631–1635.[Abstract]
46 Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu C, Ferrante J, Stewart C, Sarmiento U, Faherty DA & Gately MK. IL-12-deficient mice are defective in IFN-gamma production and type 1 cytokine responses, Immunity, 1996, 4, 471–481.[Medline]
47 Hirayama F, Katayama N, Neben S, Donaldson D, Nickbarg EB, Clark SC & Ogawa M. Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture, Blood, 1994, 83, 92–98.[Abstract/Free Full Text]
48 Jacobsen SE, Veiby OP & Smeland EB. Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells, J Exp Med, 1993, 178, 413–418.[Abstract/Free Full Text]
49 Bennett IM & Perussia B. Effects of IL-12 on human natural killer cell differentiation, NY Acad Sci, 1997, 795, 181–188.
50 Perussia B. Lymphokine-activated killer cells, natural killer cells and cytokines, Curr Opin Immunol, 1991, 3, 49–55.[Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
